We aim to deliver successful innovation and accelerated delivery of medical technologies and regenerative therapies to patients. We focus on developing enhanced methods to diagnose and target individual patients to support the commercial development of new technologies that will deliver 50 active years after 50®.
Ceramic hip joint
The global market for medical technology presents a significant innovation opportunity and is valued at £200 bn with CAGR of 5.9%. The UK is recognised as a world leader in life sciences and the sector offers significant potential for high technology-led growth.
Driving growth and prosperity as well as stimulating improvements in healthcare delivery and meeting future challenges such as an aging population and obesity.
The medical technology sector is growing rapidly in the UK with more than 3,000 companies the majority of which are small and medium enterprises (SMEs). These employ 55,000 people and generate around £13 billion in turnover. Around 25% of these UK based companies invest in R&D and 40% undertake manufacturing. The UK is a net exporter of medical technology with 25% all the European medical technology companies being based in the UK. Currently the regenerative medicine sector within medical technology is less than 1% of this £13 billion but also offers significant potential for further development.